Integrin Receptor Imaging of Breast Cancer: A Proof-of-Concept Study to Evaluate 99mTc-NC100692
Tore Bach-Gansmo1,
Rimma Danielsson2,
Ariel Saracco2,
Brigitte Wilczek2,
Trond V. Bogsrud1,
Anne Fangberget1,
Åse Tangerud3 and
Derek Tobin4
1 RikshospitaletRadiumhospitalet Medical Center, Oslo, Norway; 2 Division of Radiology, Karolinska Institutet, Stockholm, Sweden; 3 Asker and Bærum Hospital, Bærum, Norway; and 4 GE Healthcare, Oslo, Norway

View larger version (102K):
[in a new window]
|
FIGURE 1. Patient 1: Infiltrative ductal carcinoma (8 mm). Lateral projection.
|
|

View larger version (154K):
[in a new window]
|
FIGURE 2. Patient 3: Infiltrative ductal carcinoma (10 mm), with surrounding ductal carcinoma in situ. Frontal projection.
|
|

View larger version (116K):
[in a new window]
|
FIGURE 3. Patient 14: Large infiltrative ductal carcinoma (35 mm) (large arrow) with uptake in axillary lymph nodes (small arrow). Frontal projection.
|
|

View larger version (54K):
[in a new window]
|
FIGURE 4. Patient 10: Diffuse, heterogeneous uptake in fibrocystic disease, with no focal pathology. Lateral projection.
|
|

View larger version (110K):
[in a new window]
|
FIGURE 5. Patient 19: Intense uptake in infected cyst. SPECT, coronal projection.
|
|
Copyright © 2006 by the Society of Nuclear Medicine.